Gene · 5698
Papers4,120
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 4,120
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Epstein‒Barr virus and human herpesvirus 6 infection in patients with systemic lupus erythematosus. | Virol J | 2023 | 36782252 | PubTator, text mining | PubMed |
| Identification of tumor antigens and immune subtypes of acute myeloid leukemia for mRNA vaccine development. | Clin Transl Oncol | 2023 | 36781600 | PubTator, text mining | PubMed |
| Emerging predictive biomarkers for novel therapeutics in peripheral T-cell and natural killer/T-cell lymphoma. | Front Immunol | 2023 | 36776886 | PubTator, text mining | PubMed |
| Dysregulation of Gene Expression of Key Signaling Mediators in PBMCs from People with Type 2 Diabetes Mellitus. | Int J Mol Sci | 2023 | 36769056 | PubTator, text mining | PubMed |
| Transcriptomic and Functional Evidence That miRNA193a-3p Inhibits Lymphatic Endothelial Cell (LEC) and LEC + MCF-7 Spheroid Growth Directly and by Altering MCF-7 Secretome. | Cells | 2023 | 36766731 | PubTator, text mining | PubMed |
| HGCA2.0: An RNA-Seq Based Webtool for Gene Coexpression Analysis in Homo sapiens. | Cells | 2023 | 36766730 | PubTator, text mining | PubMed |
| Epigenetic Perspective of Immunotherapy for Cancers. | Cells | 2023 | 36766706 | PubTator, text mining | PubMed |
| EBV dUTPase: A Novel Modulator of Inflammation and the Tumor Microenvironment in EBV-Associated Malignancies. | Cancers (Basel) | 2023 | 36765813 | PubTator, text mining | PubMed |
| BCG-induced trained immunity: history, mechanisms and potential applications. | J Transl Med | 2023 | 36765373 | PubTator, text mining | PubMed |
| The mode of action of tapasin on major histocompatibility class I (MHC-I) molecules. | J Biol Chem | 2023 | 36758805 | PubTator, text mining | PubMed |
| Adoptive cellular immunotherapy for solid neoplasms beyond CAR-T. | Mol Cancer | 2023 | 36750830 | PubTator, text mining | PubMed |
| Increased expression of the immunoproteasome subunits PSMB8 and PSMB9 by cancer cells correlate with better outcomes for triple-negative breast cancers. | Sci Rep | 2023 | 36746983 | PubTator, text mining | PubMed |
| Low-dose interleukin-2 promotes immune regulation in face transplantation: A pilot study. | Am J Transplant | 2023 | 36740193 | PubTator, text mining | PubMed |
| Identification of essential genes and immune cell infiltration in rheumatoid arthritis by bioinformatics analysis. | Sci Rep | 2023 | 36739468 | PubTator, text mining | PubMed |
| Differential angiogenesis of bone and muscle endothelium in aging and inflammatory processes. | Commun Biol | 2023 | 36721025 | PubTator, text mining | PubMed |
| Identification of EMP1 as a critical gene for cisplatin resistance in ovarian cancer by using integrated bioinformatics analysis. | Cancer Med | 2023 | 36708070 | PubTator, text mining | PubMed |
| CD28-CAR-T cell activation through FYN kinase signaling rather than LCK enhances therapeutic performance. | Cell Rep Med | 2023 | 36696897 | PubTator, text mining | PubMed |
| A Homozygous PPP1R21 Splice Variant Associated with Severe Developmental Delay, Absence of Speech, and Muscle Weakness Leads to Activated Proteasome Function. | Mol Neurobiol | 2023 | 36692708 | PubTator, text mining | PubMed |
| Radiotherapy enhances CXCR3highCD8+ T cell activation through inducing IFNγ-mediated CXCL10 and ICAM-1 expression in lung cancer cells. | Cancer Immunol Immunother | 2023 | 36688994 | PubTator, text mining | PubMed |
| The Fight against the Carcinogenic Epstein-Barr Virus: Gut Microbiota, Natural Medicines, and Beyond. | Int J Mol Sci | 2023 | 36675232 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5698/papers?page=25